An evaluation of the performance of OraQuick® ADVANCE Rapid HIV-1/2 Test in a high-risk population attending genitourinary medicine clinics in East London, UK

International Journal of STD and AIDS

Volumn 19, Issue 10, 2008, Pages 665-667

  Zelin, J ^a,b   Garrett, N ^c   Saunders, J ^d   Warburton, F ^b,e   Anderson, J ^c   Moir, K ^a,b   Symonds, M ^a,b   Estcourt, C ^a,b,f,g,h  

^a Barts Sexual Health Centre   (United Kingdom)

^b NATIONAL HEALTH SERVICE   (United Kingdom)

^c HOMERTON UNIVERSITY HOSPITAL   (United Kingdom)

^d NEWHAM UNIVERSITY HOSPITAL   (United Kingdom)

^e Joint Research Office   (Italy)

^f Centre For Infectious Disease   (United Kingdom)

^g QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^h London School of Medicine and Dentistry ^*

Author keywords

HIV; Oral fluid; Point of care; Rapid; Tests

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ADULT; ANTIBODY DETECTION; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC KIT; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; ENZYME IMMUNOASSAY; EVALUATION; FALSE NEGATIVE RESULT; FEMALE; HIGH RISK POPULATION; HOSPITAL DEPARTMENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; MAJOR CLINICAL STUDY; MALE; MEDICINE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; UNITED KINGDOM; UROGENITAL SYSTEM;

ADULT; AIDS SERODIAGNOSIS; AMBULATORY CARE FACILITIES; FEMALE; HIV ANTIBODIES; HIV INFECTIONS; HIV-1; HIV-2; HUMANS; LONDON; MALE; PREDICTIVE VALUE OF TESTS; REAGENT KITS, DIAGNOSTIC; RISK; SALIVA; SENSITIVITY AND SPECIFICITY; TIME FACTORS; UROGENITAL SYSTEM;

EID: 53549091596     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/ijsa.2008.008132     Document Type: Article

References (19)

1. Winter AJ, Sulaiman Z, Hawkins D. BASHH Clinical Governance Committee Guidance on the appropriate use of HIV point of care tests. Int J STD AIDS 2006;17:802-5
2. Dewsnap CH, McOwan A. A review of HIV point-of-care-tests. Int J STD AIDS 2006;17:357-9
3. San Antonio-Gaddy M, Richardson-Moore A, Burstein GR, et al. Rapid HIV antibody testing in the New York State anonymous HIV counseling and testing program: experience from the field. J Acquir Immune Defic Syndr 2006;43:446-50
4. Giles RE, Crocker S, Perry KR, Parry JV, Mortimer PP. Abbott Determine HIV-1/2 Simple/Rapid Test Device. Medical Devices Agency Evaluation Report, 1998. See [http://www.hpa-midas.org.uk/reports/reports_hiv.asp] (last checked 25 January 2008)
5. Delaney KP, Branson BM, Uniyal A, et al. Performance of an oral fluid rapid HIV-1/2 test: experience from four CDC studies. AIDS 2006;20:1655-60
6. Pant Pai N, Joshi R, Dogra S, et al. Evaluation of diagnostic accuracy, feasibility and client preference for rapid oral fluid-based diagnosis of HIV infection in rural India. PLoS ONE 2007;2:e367
7. Gardner MJ, Altman DG. Calculating confidence intervals for proportions and their differences. In: Gardner MJ, Altman DG, eds. Statistics with Confidence. London: BMJ Publishing Group, 1989:28-33
8. HIV 1/0/2 Enhanced 03162506 Rev A, 2005-2012. ADVIA Centaur Assay Manual. Tarrytown, NY: Bayer HealthCare LLC, 2005
9. Gallo D, George JR, Fitchen JH, et al. Evaluation of a system using oral mucosal transudate for HIV-1 antibody screening and confirmatory testing. Orasure Clinical Trials Group. JAMA 1997;277:254-8
10. Rogstad KE, Palfreeman A, Rooney G, et al. United Kingdom National Guidelines on HIV Testing 2006, Clinical Effectiveness Group British Association of Sexual Health and HIV. See [http://www.bashh.org/guidelines/2006/ hiv_testing_juneO6.pdf] (last checked November 2007)
11. The UK Collaborative Group for HIV and STI Surveillance. Testing Times. HIV and Other Sexually Transmitted Infections in the United Kingdom. London: Health Protection Agency, Centre for Infections, 2007. See [http://www.hpa.org.uk/infections/topics_az/hiv_and_sti/Default.htm] (last checked January 2008)
12. Joint United Nations Programme on HTV/AIDS (UNAIDS) and World Health Organization (WHO). AIDS Epidemic Update, December 2007. See [http://www.unaids.org/en/KnowledgeCentre/HIVData/EpiUpdate/EpiUpdArc hive/2007/default.asp] (last checked January 2008)
13. The National Strategy for Sexual Health and HIV, Department of Health, 21 July 2001. See [http://www.dh.gov.uk/dr_consum_dh/groups/dh_digitalassets/@dh/ @en/documents/digitalasset/dh_4058945.pdf] (last checked January 2008)
14. World Health Organization. HIV Assays: Operational Characteristics (Phase I) Report 12. See [http://www.who.int/diagnostics-laboratory/ publications] (last checked November 2007)
15. Branson BM. Point-of-care rapid tests for HIV antibodies. J Lab Med 2003;27:288-95
16. ECRI Institute. Rapid HIV test kits (evaluation). Health Devices 2006 May;35(5):157-77. See [http://www.ecri.org] (last checked March 2008)
17. Rapid HIV testing: 2005 update (slide presentation online). See [www.cdc. gov/hiv/rapid_testing] (last checked March 2008)
18. World Health Organization. HIV Assays: Operational Characteristics (Phase I) Report 14. See [http://www.who.int/diagnostics-laboratory/ publications] (last checked March 2008)
19. Smit EJ. Screening guidelines for sexually transmitted Infections: human immunodeficiency virus (HIV). In: Screening Guideline Steering Group Sexually Transmitted Infections: UK National Screening and Testing Guidelines. See [http://www.bashh.org/guidelines/2006/sti_screening_guidelines_vl4_0806.pdf] (last checked February 2008)